| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News + Adhoc | Bilanz/GuV | Termine | Zertifikate | Depot |
| Times + Sales | Chart-Analyse | Analysen | Dividende/HV | Profil | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Kursziele | Insidertrades | Knock-outs | myHome | |
| Orderbuch | Realtime Stuttgart | RSS Feed | im Forum | Fonds | Senden/Drucken | |
| Historisch | Realtime Push | myNews neu | IR-Daten | Anleihen | handeln | |
K-V Pharmaceutical a zu myNews hinzufügen Was ist das?
KV Pharmaceutical Company (NYSE: KV-A) will hold an analyst conference call at 4 p.m. EST (3 p.m. CST) today to introduce interim CEO David Van Vliet. On the call, Mr. Van Vliet, and Mike Anderson, president and chief executive officer of the company’s ETHEX subsidiary, will discuss the company’s strategy and direction.
A live webcast of the conference call will be available to all investors at the KV Pharmaceutical Web site at www.kvpharmaceutical.com or at: http://w.on24.com/r.htm?e=129545&s=1&k=9EA4A6B58D4E4CD664B17BB109450C1F.
For those who cannot listen to the live broadcast, an audio replay of the call will be available on these Web sites until March 9, 2009.
About KV Pharmaceutical Company
KV Pharmaceutical Company is a fully integrated specialty pharmaceutical company that develops, manufactures, markets, and acquires technology-distinguished branded and generic/non-branded prescription pharmaceutical products. The company markets its technology distinguished products through ETHEX Corporation, a national leader in pharmaceuticals that compete with branded products, and Ther-Rx Corporation, its branded drug subsidiary.
| Geben Sie jetzt einen Kommentar zu diesem Artikel ab. |
| 27.01.09 | K-V Pharmaceutical Downgrade | ROTH Capital Partners, LLC | |
| 26.01.09 | K-V Pharmaceutical neues Kursziel | ROTH Capital Partners, LLC | |
| 11.12.08 | K-V Pharmaceutical buy | ROTH Capital Partners, LLC | |
| 12.08.08 | K-V Pharmaceutical Downgrade | ROTH Capital Partners, LLC | |
| 17.06.08 | K-V Pharmaceutical neues Kursziel | ROTH Capital Partners, LLC |
| 26.01.09 | K-V Pharmaceutical neues Kursziel | ROTH Capital Partners, LLC | |
| 11.12.08 | K-V Pharmaceutical buy | ROTH Capital Partners, LLC | |
| 17.06.08 | K-V Pharmaceutical neues Kursziel | ROTH Capital Partners, LLC | |
| 31.07.07 | K-V Pharmaceutical neues Kursziel | Roth Capital | |
| 20.06.07 | K-V Pharmaceutical buy | Roth Capital |
| 27.01.09 | K-V Pharmaceutical Downgrade | ROTH Capital Partners, LLC | |
| 12.08.08 | K-V Pharmaceutical Downgrade | ROTH Capital Partners, LLC | |
| 15.06.07 | K-V Pharmaceutical Downgrade | Roth Capital | |
| 20.07.06 | K-V Pharmaceutical Ersteinschätzung | JP Morgan | |
| 20.01.06 | Update K-V Pharmaceutical Co. (A): Hold | Deutsche Securities |
| 16.08.06 | Update K-V Pharmaceutical Co. (A): Strong Sell | Matrix Research | |
| 16.08.06 | Update K-V Pharmaceutical Co. (A): Strong Sell | Matrix Research |
Alle: Alle Empfehlungen
Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
| K-V Pharmaceutical Co. (A) | 0,89 | -1,44% |
| Keine Nachrichten gefunden. |
| Keine Nachrichten gefunden. |
| 21.05.2012 | Die wertvollsten Fußball-Klubs der Welt |
| 24.04.2012 | Die besten Chefs der Welt |
| 12.04.2012 | Welche DAX-Konzerne ihre Anleger überschütten |
| 23.04.2012 | Mit diesen Autos greifen die Deutschen in China an |
| 29.05.2012 | Geheime Einblicke in den Kommunismus |
